Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population

Clinical and Experimental Nephrology

Volumn 18, Issue 3, 2014, Pages 461-468

  Shiraishi, Naoki ^a   Kitamura, Kenichiro ^a   Kohda, Yukimasa ^a   Iseki, Kunitoshi ^b   Tomita, Kimio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

Hypertension; Hypertensive nephrosclerosis; Ischemic nephropathy; Nephrosclerosis; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; INCIDENCE; ISCHEMIC NEPHROPATHY; JAPANESE (PEOPLE); KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; OBESITY; PREVALENCE; RISK FACTOR; SMOKING; AGE; COMPLICATION; ISCHEMIA; JAPAN; KIDNEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; VASCULARIZATION;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; ISCHEMIA; JAPAN; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPHROSCLEROSIS; OBESITY; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84903376786     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0833-5     Document Type: Article

References (18)

1. Szwed JJ. Urinalysis and clinical renal disease. Am J Med Technol. 1980;46:720-5.
2. Takebayashi S, Kiyoshi Y, Hisano S, Uesugi N, Sasatomi Y, Meng J, Sakata N. Benign nephrosclerosis: incidence, morphology and prognosis. Clin Nephrol. 2001;55:349-56. (Pubitemid 32427916)
3. Lerman LO, Textor SC, Grande JP. Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. Prog Cardiovasc Dis. 2009;52:196-203.
4. Zucchelli P, Zuccalà A. Recent data on hypertension and progressive renal disease. J Hum Hypertens. 1996;10:679-82. (Pubitemid 27037517)
5. The Committee of Japanese Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 2010;53:450-67.
6. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi. 2005;94:794-809.
7. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan; Collaborators developing the Japanese equation for estimated GFR. Am J Kidney Dis. 2009;53:982-92.
8. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621-30.
9. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404-11. (Pubitemid 36724404)
10. Diez Ojea B, Marín R, Coto E, Fernández Vega F, Alvarez Navascués R, Fernández Fresnedo G, Pobes Martínez de Salinas A, Suárez Laurés A, García Monteavaro C, Gorostidi M, Sánchez E, Arias M, Ortega F. Clinical and genetic basis of hypertensive nephrosclerosis. NEFROSEN study. Nefrologia. 2010;30:687-97.
11. Kalaitzidis RG, Siamopoulos KC. The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol. 2011;43:771-84.
12. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44:642-50. (Pubitemid 39237608)
13. Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant. 1997;12:1908-15. (Pubitemid 27379464)
14. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159-66. (Pubitemid 46094690)
15. Noborisaka Y, Ishizaki M, Yamada Y. Paradoxical signs of smoking-induced chronic kidney disease (CKD) in generally healthy populations, especially those from workplaces. J Kanazawa Med Univ. 2011;36:98-105.
16. Marín R, Gorostidi M, Fernández-Vega F, Alvarez-Navascués R. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int Suppl. 2005:S52-56.
17. Tomson CR, Petersen K, Heagerty AM. Does treated essential hypertension result in renal impairment? A cohort study. J Hum Hypertens. 1991;5:189-92.
18. Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens. 2001;15:99-106.